Risk stratification by pharmacological stress echocardiography in a primary care cardiology centre

European Heart Journal

Volumn 19, Issue 11, 1998, Pages 1673-1680

  Cortigiani, Lauro ^a,c   Lombardi, M ^b   Landi, P ^b   Paolini, E A ^a   Nannini, E ^a  

^a Lucca Hospital   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^c CAMPO DI MARTE HOSPITAL   (Italy)

Author keywords

Coronary artery disease; Dipyridamole; Dobutamine; Prognosis; Stress echocardiography

Indexed keywords

DIPYRIDAMOLE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCHOLESTEROLEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RISK ASSESSMENT; SAFETY; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE;

AGED; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIPYRIDAMOLE; DOBUTAMINE; FEASIBILITY STUDIES; FEMALE; HOSPITALS, GENERAL; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; VASODILATOR AGENTS;

EID: 0032213414     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1096     Document Type: Article

References (38)

1. [1] Younis LT, Chaitman BR. The prognostic value of exercise testing. Cardiol Clin 1993; 11: 229-40.
2. [2] Chaitman BR. Exercise stress testing. In: Braunwald E, ed. Heart Disease: a textbook of cardiovascular Medicine, 5th edn. Philadelphia, Pa: WB Saunders Co, 1997: 153-76.
3. [3] Hecht HS, Shaw RE, Bruce T, Myler RK. Silent ischemia: evaluation by exercise and redistribution tomographic thallium-201 myocardial imaging. J Am Coll Cardiol 1989; 14: 895-900.
4. [4] Mahmarian JJ, Pratt CM, Cocanougher MK, Varani MS. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography. Circulation 1990; 82: 1305-15.
5. [5] Picano E, Marini C, Pirelli S et al. Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 1992; 70: 252-8.
6. [6] Mertes , Sawada SG, Ryan T et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 1993; 88: 15-9.
7. [7] Picano E, Mathias Jr W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Lancet 1994; 344: 1190-2.
8. [8] Poldermans D, Fioretti PM, Boersma E et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease: experience in 650 consecutive examinations. Am J Cardiol 1994; 73: 456-9.
9. [9] Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986; 8: 846-54.
10. [10] Labovitz AJ, Pearson AC, Chaitman BR. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am J Cardiol 1988; 62:1180-5.
11. [11] Severi S, Picano E, Michelassi C et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease. Comparison with exercise electrocardiography. Circulation 1994; 89: 1160-73.
12. [12] Cohen JL, Greene TO, Ottenweller J, Binebaum SZ, Wichfort SD, Kim CS. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991; 67: 1311-8.
13. [13] Sawada SG, Segar DS, Ryan T, Dohan AM, Williams R, Feigenbaum H. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991; 83: 1605-14.
14. [14] Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992; 19: 1203-11.
15. [15] Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69: 1269-73.
16. [16] Salustri A, Fioretti PM, Pozzoli MM, McNeill AJ, Roelandt JRTC. Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease. Eur Heart J 1992; 13: 70-7.
17. [17] Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity and predictive value for future cardiac events. Am Heart J 1994; 127: 1510-5.
18. [18] Pingitore A, Picano E, Quarta Colosso M et al. The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1996; 27: 1164-70.
19. [19] Picano E, Severi S, Michelassi C et al. Prognostic importance of dipyridamole-echocardiography test in coronary artery disease. Circulation 1989; 80: 450-7.
20. [20] Bolognese L, Sarasso G, Piccinino C, Rossi L, Bongo A, Rossi P. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992; 19: 953-9.
21. [21] Picano E, Landi P, Bolognese L et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. Am J Med 1993; 95: 608-18.
22. [22] Mazeika PK, Nadazdin A, Oakley C. Prognostic value of dobutamine echocardiography in patients with high pretest likelihood of coronary artery disease. Am J Cardiol 1993; 71: 33-9.
23. [23] Poldermans D, Fioretti PM, Boersma E et al. Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med 1994; 97: 119-25.
24. [24] Minardi G, Disegni M, Manzara C et al. Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with acute myocardial infarction. Am J Cardiol 1997; 80: 847-51.
25. [25] Sicari R, Picano E, Landi P et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardiol 1997; 29: 254-60.
26. [26] Geleijnse ML, Elhendy A, van Domburg RT et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? Circulation 1997; 96: 137-47.
27. [27] Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol 1987; 60: 508-12.
28. [28] Masini M, Picano E, Lattanzi F, Distante A, L'Abbate A. High dose dipyridamole-echocardiography test in women: correlation with exercise-electrocardiography test and coronary arteriography. J Am Coll Cardiol 1988; 12: 682-5.
29. [29] Picano E, Lucarini AR, Lattanzi F et al. Dipyridamole echocardiography in essential hypertensive patients with chest pain. Hypertension 1988; 12: 238-43.
30. [30] Geleijnse ML, Salustri A, Marwick TH, Fioretti PM. Should the diagnosis of coronary artery disease be based on the evaluation of myocardial function or perfusion? Eur Heart J 1997; 18 (Suppl D): D68-D77.
31. [31] Picano E, Pingitore A, Conti U et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 1993; 14: 1216-22.
32. [32] McNeill AJ, Fioretti PM, El-Said ESM, Salustri A, Forster T, Roelandt JRTC. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992; 70: 41-6.
33. [33] Schiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-67.
34. [34] Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilising the 'biphasic' response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995; 26: 26-32.
35. [35] Arnese M, Fioretti P, Cornel J, Postma-Tjoia J, Rejis A, Roelandt J. Akinesis becoming dyskinesis during high dose dobutamine stress echocardiography: a marker of ischemia or a purely mechanical phenomenon? Am J Cardiol 1994; 73: 896-9.
36. [36] Quintana M, Lindvall K, Brolund F, Storck N, Lindblad LE, Ryden L. Markers of risk after acute myocardial infarction. A comparison of clinical variables, ambulatory and exercise electrocardiography, echocardiography, and stress echocardiography. Cor Art Dis 1997; 8: 327-34.
37. [37] Picano E, Lattanzi F, Orlandini A, Marini C, L'Abbate A. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991; 17: 666-9.
38. [38] Varga A, Picano E, Cortigiani L et al. Is stress echocardiography capable to predict the site of future myocardial infarction? A large scale multicenter study. J Am Coll Cardiol 1996; 28: 45-51.